lapatinib

Ukraine

Drugs containing this active substance

  • LAPATINIB-VISTA

    The drug is prescribed for adult women with HER2-positive breast cancer. It is used as part of combination therapy with capecitabine, trastuzumab, or aromatase inhibitors, depending on the type and stage of the disease.

    Form: tablets, film-coated

    Active substance Dosage
    lapatinib 250 mg

    ATC: L01XE07

    Manufacturer: Faros MT Limited

  • TYVERB

    The drug is intended for the treatment of adult women with HER2-positive breast cancer. It is used as part of combination therapy with capecitabine, trastuzumab, or aromatase inhibitors, depending on the type and stage of the disease.

    Form: tablets, film-coated

    Active substance Dosage
    lapatinib 250 mg

    ATC: L01EH01

    Manufacturer: Glaxo Operations UK Limited, trading as Glaxo Wellcome Operations (Manufacturing of unpackaged products, quality control)